CCS
DXCM icon

Concentric Capital Strategies’s DexCom DXCM Stock Holding History

Concentric Capital Strategies’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,408
Closed -$431K – 290
2025
Q3 		$431K Buy
+6,408
New +$507K 0.02% 272
2024
Q2 		– Sell
-30,345
Closed -$4.21M – 313
2024
Q1 		$4.21M Buy
+30,345
New +$3.81M 0.24% 104
2023
Q4 		– Sell
-10,600
Closed -$989K – 243
2023
Q3 		$989K Buy
+10,600
New +$1.19M 0.1% 140

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Concentric Capital Strategies's DXCM Position: Q4 2025 in Review

Concentric Capital Strategies sold out of DexCom (DXCM) in Q4 2025, closing a stake of 6,408 shares — an estimated $431K sold.

Concentric Capital Strategies first reported a position in DXCM in Q3 2023 and held it in 3 quarters. The position peaked at $4.21M in Q1 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Concentric Capital Strategies reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Concentric Capital Strategies sold 6,408 DexCom shares in Q4 2025, an estimated $431K.
  • Concentric Capital Strategies first reported a position in DexCom in Q3 2023 and held it in 3 quarters.
  • Concentric Capital Strategies's DexCom position peaked at $4.21M in Q1 2024.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Concentric Capital Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.